Endocrinologists are scientists and medical doctors who specialize in unraveling the mysteries of hormone disorders to care for patients and treat diseases. These professionals have achieved breakthroughs in scientific discoveries and clinical care benefiting people with hundreds of conditions, including diabetes, thyroid disorders, obesity, hormone-related cancers, growth problems, osteoporosis and infertility.
Established in 1944, the Society’s Laureate Awards recognize the highest achievements in the endocrinology field, including groundbreaking research and innovations in clinical care. The Endocrine Society will present the awards to the winners at ENDO 2026, the Society’s annual meeting, being held June 13-16, in Chicago, Ill.
The Endocrine Society’s 2026 Laureate Award winners are:
Robert M. Carey, M.D., M.A.C.P.– Fred Conrad Koch Lifetime Achievement Award. The Society’s highest honor, this annual award recognizes lifetime achievements and exceptional contributions to the field of endocrinology. Carey is a Professor of Medicine and Dean Emeritus at the University of Virginia School of Medicine in Charlottesville, Va. He is a world-renowned clinical endocrinologist and leader in cardiovascular endocrinology. He is being recognized for his leadership in clinical hypertension, including treating patients, conducting groundbreaking research, and enhancing our understanding of hormonal control of blood pressure. Carey has made major contributions to our understanding of the renin-angiotensin system (RAS), the renal dopaminergic system and mechanisms of pressure-natriuresis. His studies encompass a combination of cellular and molecular approaches, in vivo animal experiments and patient-oriented clinical investigation. He is a very active member of the Endocrine Society who has served on many committees and task forces. He was President of the Society in 2008 and is a past recipient of the Distinguished Physician Award and the Outstanding Leadership Award. He is currently a member of the Society’s Primary Aldosteronism Guideline Development Panel.
Christopher Kevin Glass, M.D., Ph.D. – Edwin B. Astwood Award for Outstanding Research in Basic Science. Originally awarded from 1967 and renamed to honor the scientific contributions of the late Dr. Edwin B. Astwood, this award recognizes individuals who have made significant contributions to the field of endocrinology via their outstanding basic science research. Glass is Professor of Cellular and Molecular Medicine and Professor of Medicine at the University of California San Diego in San Diego, Calif. He is being recognized for his novel research that uncovered how nuclear hormone receptors and other signal-dependent transcription factors regulate the development and functions of macrophages, which play key roles in immune responses and are major contributors to nearly all chronic diseases. These findings provided evidence that therapeutic targeting of macrophages could inhibit the development of atherosclerosis independent of changes in circulating cholesterol levels.
Rebecca Reynolds, M.D., Ph.D. – International Excellence in Endocrinology Award. This award is presented to an endocrinologist who has made exceptional contributions to the field in geographic areas with underdeveloped resources for hormone health research, education, clinical practice or administration. Reynolds is Personal Chair of Metabolic Medicine and Dean International at the College of Medicine and Veterinary Medicine, University of Edinburgh in Edinburgh, United Kingdom. As a physician scientist, her research focuses on women’s health in pregnancy and the health of next and future generations, with a particular focus on low- and middle-income countries (LMICs). Her work contributes directly to the discovery of new interventions to improve pregnancy outcomes. She has fostered partnerships between her university and LMICs and leads a teaching program with numerous international students.
Samuel Klein, M.D. – Outstanding Clinical Investigator Award. This annual award honors an internationally recognized clinical investigator who has contributed significantly to understanding the pathogenesis and therapy of endocrine and metabolic diseases. Klein is the William H. Danforth Professor of Medicine at the Washington University School of Medicine in St. Louis, Mo. He uses a combination of sophisticated basic and clinical science research techniques to address clinically relevant questions in human subjects, which are ultimately directed to improving health and patient care. His research is focused on understanding the cellular and multi-organ system physiological mechanisms responsible for the heterogeneity in metabolic dysfunction associated with obesity, prediabetes, diabetes, and the therapeutic effects of weight loss. He also has conducted important clinical trials that evaluated the efficacy and metabolic effects of weight reduction therapies.
Lisa B. Nachtigall, M.D. – Vigersky Outstanding Clinical Practitioner Award. This annual award recognizes extraordinary contributions by a practicing endocrinologist to the endocrine and/or medical community. Nachtigall is the Clinical Director of the Neuroendocrine Clinical Center at Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School in Boston, Mass. In addition, she is the Director of MGH International Education Programs for the MGB/MGH Endocrine Division, and of the MGH/Harvard Medical School advanced clerkship in Clinical Neuroendocrinology. She has extensive clinical experience in all pituitary disorders, particularly acromegaly. She is an internationally recognized clinical expert, who speaks nationally and internationally and has published extensively in the field of pituitary care. She has co-founded and directs a visiting scholars program encouraging a pipeline of students and trainees in endocrine. She has been an impactful advocate for patients with rare disorders, including organizing educational programs for patients with acromegaly. She has served on multiple Endocrine Society committees and task forces.
Bradley David Anawalt, M.D. – Outstanding Educator Award. This annual award recognizes exceptional achievement as an educator in the discipline of endocrinology and metabolism. Anawalt is a Professor and Vice Chair in the Department of Medicine at the University of Washington School of Medicine in Seattle, Wash. He is a world expert in andrology and the diagnosis and treatment of male hypogonadism. He also is a dedicated teacher, known for his ability to convey not only factual material, but a sense of collegiality and joy in learning among his students. He has held numerous service positions with the Endocrine Society and is currently a member of its Endocrine Self-Assessment Program (ESAP™) Faculty Group and CoDI. He’s also a regular presenter at ENDO, the Society’s annual meeting.
Patricia Lee Brubaker, Ph.D. – Outstanding Mentor Award. This annual award recognizes a career commitment to mentoring and a significant positive impact on mentees’ education and career. Brubaker is a Professor Emerita in the Departments of Physiology and Medicine at the University of Toronto in Ontario, Canada. Since 1985, she has had the privilege of mentoring hundreds of post-doctoral fellows and graduate and undergraduate research students. Under her mentorship, she provides her students with a roadmap for success in their chosen careers, and her students have gone on to publish papers in high-impact journals. Many of her undergraduate trainees remain in her laboratory over extended terms, and she has continued to mentor many of her trainees for years post-graduation. She is currently Chair of the Endocrine Society’s Publications Core Committee and was the Associate Editor of Endocrinology, the Society’s basic science journal.
Martin Reincke, M.D. – Outstanding Scholarly Physician Award. This annual award recognizes outstanding contributions to the practice of clinical endocrinology in academic settings. Reincke is a Professor of Endocrinology and Chair of Medical Department IV at the Ludwig-Maximilians University Hospital in Munich, Germany—one of the leading institutions in German academic medicine. He is an internationally recognized leader in the diagnosis and management of adrenal and pituitary disorders who played a key role in building a large-scale international research consortia to address major therapeutic challenges in patients with primary aldosteronism and Cushing’s syndrome. He previously served on the Editorial Board of The Journal of Clinical Endocrinology & Metabolism.
Katrin J. Svensson, Ph.D. – Richard E. Weitzman Outstanding Early Career Investigator Award. This annual award recognizes an exceptionally promising young clinical or basic investigator. Svensson is an Associate Professor in the Department of Pathology at Stanford University, and the Metabolic Core Director and Affinity Group Leader at the Stanford Diabetes Research Center in Palo Alto, Calif. Her research focuses on understanding intercellular communication to maintain metabolic homeostasis, with a particular emphasis on secreted signaling molecules and peptides. Her laboratory discovered Isthmin, a secreted protein that regulates insulin independent glucose uptake and lipid homeostasis. Additionally, her group developed computational methods to predict new peptides and ligand-receptor pairs, advancing the discovery of novel endocrine pathways.
Alvin C. Powers, M.D. – Roy O. Greep Award for Outstanding Research. This annual award recognizes meritorious contributions to research in endocrinology. Powers is the Joe C. Davis Chair in Biologic Science, Professor of Medicine and Molecular Physiology and Biophysics, and Director of the Vanderbilt Diabetes Center (VDC) at Vanderbilt University Medical Center in Nashville, Tenn. Powers is a physician-scientist who has made fundamental research discoveries revealing how alterations in islet biology are linked to the pathogenesis of type 1 and type 2 diabetes, cystic fibrosis-related diabetes, monogenic diabetes and posttransplant diabetes. The work of his research group, especially the emphasis on translating research on human islet biology into advancing human diabetes research, has redefined our understanding of islet structure and function and its role in glucose homeostasis and diabetes. Powers has served on several Endocrine Society committees and task forces and is an author of the Society’s recent Scientific Statement on type 1 diabetes.
R. Paul Robertson, M.D. – Sidney H. Ingbar Distinguished Service Award. This award recognizes distinguished service to the Endocrine Society and the field of endocrinology. Robertson is Professor Emeritus at the University of Washington School of Medicine in Seattle, Wash. He has made numerous scientific contributions to endocrinology over the course of his career with research that improves our understanding of pancreatic islet function in humans, animals and clonal cell lines. He’s served in numerous leadership roles at the Endocrine Society, the National Institutes of Health, and many other scholarly societies and institutes. At the Endocrine Society, he’s served as Editor-in-Chief of The Journal of Clinical Endocrinology & Metabolism and Endocrine Reviews, and as a member of the Society’s Publications Core Committee.
Ismaa Sadaf Farooqi, M.D., Ph.D. – Gerald D. Aurbach Award for Outstanding Translational Research. This annual award recognizes outstanding contributions to research that accelerates the transition of scientific discoveries into clinical applications. Farooqi is a Clinician Scientist at the Institute of Metabolic Science at the University of Cambridge in Cambridge, U.K., who is being honored for her discoveries of fundamental mechanisms that control human energy homeostasis. With colleagues, she discovered the first genes whose disruption causes severe obesity. In pioneering clinical studies, she established that the principal driver of human obesity is a failure of the central control of appetite and that the leptin-melanocortin pathway regulates food intake, macronutrient preference, food reward and body weight. Her research has changed the investigation, management and treatment of children and adults with severe obesity.
Nominations are being accepted for the 2027 awards cycle until January 20, 2026. Any submissions received after that will be considered for the following year.
# # #
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X at @TheEndoSociety and @EndoMedia.
END